Endothelial dysfuntion in children with idiopathic nephrotic syndrome

Atherosclerosis. 2014 Apr;233(2):704-706. doi: 10.1016/j.atherosclerosis.2014.01.055. Epub 2014 Feb 11.

Abstract

Background: Impaired endothelial function is the initial step in atherogenesis, which is largely responsible for ischaemic heart disease and thrombotic strokes decades later.

Methods: Fourty two children with first episode nephrotic syndrome (FENS) aged 1-16 years and 40 controls were enrolled. Soluble thrombomodulin (sTM), tissue plasminogen activator (t-PA), plasminogen activator inhibitor -1 (PAI-1) and von-willebrand factor (vWF) levels were measured in plasma in FENS, at 12 weeks of drug induced remission and in steroid resistant nephrotic syndrome (SRNS) patients at diagnosis.

Results: PAI-1, sTM, vWF and t-PA were significantly raised at the onset of nephrotic syndrome (p<0.0001). All the markers had a fall after 12 weeks of steroid treatment, but were still raised. Children with SRNS had higher levels of sTM, tPA, vWF as compared to infrequent relapsers, at onset and at 4 weeks of steroid treatment.

Conclusion: Children with idiopathic nephrotic syndrome have endothelial dysfunction which is largely dependent upon disease activity.

Keywords: Children; Endothelial dysfunction; Nephrotic syndrome.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Adrenal Cortex Hormones / therapeutic use
  • Biomarkers
  • Child
  • Child, Preschool
  • Drug Resistance
  • Endothelium, Vascular / physiopathology*
  • Female
  • Follow-Up Studies
  • Humans
  • Infant
  • Lipids / blood
  • Male
  • Nephrotic Syndrome / blood
  • Nephrotic Syndrome / drug therapy
  • Nephrotic Syndrome / physiopathology*
  • Plasminogen Activator Inhibitor 1 / blood
  • Recurrence
  • Thrombomodulin / blood
  • Tissue Plasminogen Activator / blood
  • von Willebrand Factor / analysis

Substances

  • Adrenal Cortex Hormones
  • Biomarkers
  • Lipids
  • Plasminogen Activator Inhibitor 1
  • SERPINE1 protein, human
  • THBD protein, human
  • Thrombomodulin
  • von Willebrand Factor
  • Tissue Plasminogen Activator

Supplementary concepts

  • Nephrosis, congenital